These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 19559156)
1. It's time to bail out seniors trapped in the Medicare donut hole! Dalen JE Am J Med; 2009 Jul; 122(7):595-6. PubMed ID: 19559156 [No Abstract] [Full Text] [Related]
2. How insurers' bargaining power affects drug prices in Medicare Part D. Natl Bur Econ Res Bull Aging Health; 2009; (4):1-2. PubMed ID: 20355274 [No Abstract] [Full Text] [Related]
3. Omnicare forgot to mention ... Part D's effect not factored in its argument for hostile PharMerica takeover. Lee J Mod Healthc; 2012 Feb; 42(6):14. PubMed ID: 22356083 [No Abstract] [Full Text] [Related]
4. Price stability. No hike expected in Medicare drug plan averages. Zigmond J Mod Healthc; 2011 Aug; 41(32):11. PubMed ID: 21879693 [No Abstract] [Full Text] [Related]
6. Cost-related nonadherence in the Medicare program: the impact of Part D. Kennedy JJ; Maciejewski M; Liu D; Blodgett E Med Care; 2011 May; 49(5):522-6. PubMed ID: 21430574 [TBL] [Abstract][Full Text] [Related]
7. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief. Chaps NA Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435 [No Abstract] [Full Text] [Related]
8. Time to fill the doughnuts--health care reform and Medicare Part D. Shrank WH; Choudhry NK N Engl J Med; 2011 Feb; 364(7):598-601. PubMed ID: 21247308 [No Abstract] [Full Text] [Related]
9. Rebates-The Little-Known Factor Behind Increasing Drug List Prices. Rubin R JAMA; 2020 Mar; 323(9):812-813. PubMed ID: 32125400 [No Abstract] [Full Text] [Related]
10. Beneficiary price sensitivity in the Medicare prescription drug plan market. Frakt AB; Pizer SD Health Econ; 2010 Jan; 19(1):88-100. PubMed ID: 19191252 [TBL] [Abstract][Full Text] [Related]
11. Cost minimization of medicare part D prescription drug plan expenditures. Patel RA; Lipton HL; Cutler TW; Smith AR; Tsunoda SM; Stebbins MR Am J Manag Care; 2009 Aug; 15(8):545-53. PubMed ID: 19670958 [TBL] [Abstract][Full Text] [Related]
12. PDPs see increases in cost-sharing amounts. Manag Care; 2009 Aug; 18(8):55. PubMed ID: 19731513 [No Abstract] [Full Text] [Related]
13. Specialty pharmacy management will become more intense. Collins S Manag Care; 2010 Oct; 19(10):20-3. PubMed ID: 21049783 [No Abstract] [Full Text] [Related]
14. Lowering Part D drug costs without direct CMS negotiations. Sipkoff M Manag Care; 2009 Sep; 18(9):11-2. PubMed ID: 19886203 [No Abstract] [Full Text] [Related]
15. It pays to compare: assisting Medicare Part D beneficiaries with enrollment yields out-of-pocket cost savings. Geonnotti KL; Upchurch G; Roth MT; Weinberger M J Am Geriatr Soc; 2011 May; 59(5):953-5. PubMed ID: 21568975 [No Abstract] [Full Text] [Related]
16. A New Safe Harbor - Turning Drug Rebates into Discounts in Medicare Part D. Gellad WF; Ennis M; Kuza CC N Engl J Med; 2019 May; 380(18):1688-1690. PubMed ID: 30946552 [No Abstract] [Full Text] [Related]
17. Remember the MaineRx. Kemp R Appl Health Econ Health Policy; 2014 Feb; 12(1):1-5. PubMed ID: 24420789 [TBL] [Abstract][Full Text] [Related]
18. Medicare program: Medicare Advantage and prescription drug programs MIPPA drug formulary & protected classes policies. Interim final rule with comment period. Centers for Medicare & Medicaid Services (CMS), HHS Fed Regist; 2009 Jan; 74(11):2881-8. PubMed ID: 19385109 [TBL] [Abstract][Full Text] [Related]
19. Doughnuts and Discounts - Changes to Medicare Part D under the Bipartisan Budget Act of 2018. Donohue JM; Huskamp HA N Engl J Med; 2018 May; 378(21):1957-1960. PubMed ID: 29791823 [No Abstract] [Full Text] [Related]
20. The Medicare Part D donut hole and healthcare reform: will the coverage gap be closed? Sullivan JA Health Care Law Mon; 2010 Jun; 2010(6):2-6. PubMed ID: 20623931 [No Abstract] [Full Text] [Related] [Next] [New Search]